News Daily News ‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last Caitlin E. Cox December 21, 2016
News Conference News AHA 2016 Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’ Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
Presentation AHA 2016 Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016
News Features Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care Caitlin E. Cox September 23, 2016
News Daily News US Government Proposes Fixed Payments for ‘Total Experience’ of MI Care, CABG Caitlin E. Cox July 26, 2016
Presentation SOLACI 2016 Left-Main Disease: When is PCI the Preferred Strategy? Presenter: Rafael Cavalcante June 08, 2016
News Daily News SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease Caitlin E. Cox May 26, 2016
News Daily News La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos Caitlin E. Cox May 26, 2016
News Daily News Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG Yael L. Maxwell May 13, 2016
News Daily News A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG Yael L. Maxwell May 13, 2016
Presentation Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI Presenter: Ambarish Pandey May 12, 2016
News Conference News ACC 2016 Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why Yael L. Maxwell April 06, 2016
News Daily News Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados Michael O'Riordan March 31, 2016
News Daily News AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited Michael O'Riordan March 31, 2016